<div class="container z-depth-1 my-4 pt-4 pb-2 px-4">
    <h1 id="scroll-anchor-6-3" class="mb-5">Abandoned</h1>
   
   
            <img src="/assets/svg/icons8/marginalia-752.png" class="img-fluid" style = "height: 250px; width: auto;">

            <p>
                Though this outcome is listed at the end of the ROADMAP, a drug repurposing project may be abandoned at any stage of the process. Some of the common reasons include:
            </p>


    <div class="row pt-5 pb-5">
        <div class="col-2 text-center">
            <img src="https://img.icons8.com/office/512/test-failed.png" class="img-fluid listIcon">
        </div>
        <div class="col-10">
            <p>
                <b>
                    Lack of efficacy
                </b>
            </p>
            <p>
                If preclinical or clinical studies do not show that the drug is effective in treating the new indication
            </p>
        </div>
    </div>
    <div class="row pb-5">
        <div class="col-2 text-center">
            <img src="https://img.icons8.com/color/512/toxic-material.png" class="img-fluid listIcon">
        </div>
        <div class="col-10">
            <p>
                <b>
                    Safety concerns
                </b>
            </p>
            <p>
                If the drug is found to have significant side effects or safety concerns
            </p>
        </div>
    </div>
    <div class="row pb-5">
        <div class="col-2 text-center">
            <img src="https://img.icons8.com/external-flat-wichaiwi/512/external-accounting-customer-validation-flat-wichaiwi.png" class="img-fluid listIcon">
        </div>
        <div class="col-10">
            <p>
                <b>
                    Lack of funding
                </b>
            </p>
            <p>
                Drug repurposing projects can be expensive, and if funding is not available to continue the project at any point
            </p>
        </div>
    </div>
    <div class="row pb-5">
        <div class="col-2 text-center">
            <img src="https://img.icons8.com/doodle/512/boring-1.png" class="img-fluid listIcon">
        </div>
        <div class="col-10">
            <p>
                <b>
                    Lack of interest from pharmaceutical companies
                </b>
            </p>
            <p>
                Pharmaceutical companies are often the sponsors of drug repurposing projects, and a company may not be interested in pursuing a particular project, either at all or past a certain point
            </p>
        </div>
    </div>
    <div class="row pb-5">
        <div class="col-2 text-center">
            <img src="https://img.icons8.com/external-flaticons-lineal-color-flat-icons/512/external-recruitment-recruitment-agency-flaticons-lineal-color-flat-icons.png" class="img-fluid listIcon">
        </div>
        <div class="col-10">
            <p>
                <b>
                    Difficulty in recruiting patients
                </b>
            </p>
            <p>
                It may be difficult to recruit enough patients for clinical trials
            </p>
        </div>
    </div>
    <div class="row pb-5">
        <div class="col-2 text-center">
            <img src="https://img.icons8.com/external-flaticons-lineal-color-flat-icons/512/external-regulation-banking-flaticons-lineal-color-flat-icons-2.png" class="img-fluid listIcon">
        </div>
        <div class="col-10">
            <p>
                <b>
                    Regulatory hurdles
                </b>
            </p>
            <p>
                The process of getting a drug approved for a new indication can be complex and time-consuming, and the project may encounter significant regulatory hurdles
            </p>
        </div>
    </div>
    <div class="row pb-5">
        <div class="col-2 text-center">
            <img src="https://img.icons8.com/external-flaticons-lineal-color-flat-icons/512/external-competition-business-flaticons-lineal-color-flat-icons.png" class="img-fluid listIcon">
        </div>
        <div class="col-10">
            <p>
                <b>
                    Competitive landscape
                </b>
            </p>
            <p>
                There may be already other drugs available that are more effective in treating the same indication
            </p>
        </div>
    </div>
    <div class="row pb-5">
        <div class="col-2 text-center">
            <img src="https://img.icons8.com/external-sbts2018-outline-color-sbts2018/512/external-cheap-black-friday-5-sbts2018-outline-color-sbts2018.png" class="img-fluid listIcon">
        </div>
        <div class="col-10">
            <p>
                <b>
                    Lack of commercial viability
                </b>
            </p>
            <p>
                If the repurposed drug is not seen as commercially viable, it may not be attractive to the pharmaceutical companies to support repurposing
            </p>
        </div>
    </div>
    <p>
        And though “abandoned” as a status has a negative connotation, it is very important to be able to filter out which drugs are most promising and which are not, and overall, having some drugs be abandoned can speed up the process of getting one that can bring the most value to the patient population.
    </p>
</div>
<div class="py-5 my-5"></div>
